Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANDA X: Angong Niuhuang Pill for Post-Cardiac Surgery Neurologic Dysfunction
NCT06723366Not yet recruiting
- Sponsor
- Nanjing Medical University
- Start
- Jan 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Angong Niuhuang Pill in cerebral infarction (2 arms), sponsored by Nanjing Medical University. Primary endpoint: National Institutes of Health Stroke Scale at 14 days. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
Angong Niuhuang Pill
03
Conditions
cerebral infarction
Beyond the preview
Go deeper on NCT06723366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06723366.